Acquisition of invasion-inhibitory antibodies specific for the 19-kDa fragment of merozoite surface protein 1 in a transmigrant population requires multiple infections

The Journal of Infectious Diseases
E Elsa Herdiana MurhandarwatiRoss L Coppel

Abstract

Antibodies against the 19 kDa C-terminal fragment of merozoite surface protein 1 (MSP1(19)) are a major component of the invasion-inhibitory response in individuals immune to malaria. We report here the acquisition of MSP1(19)-specific invasion-inhibitory antibodies in a group of transmigrants who experienced their sequential malaria infections during settlement in an area of Indonesia where malaria is highly endemic. We used 2 transgenic Plasmodium falciparum parasite lines that expressed either endogenous MSP1(19) or the homologous region from P. chabaudi to measure the MSP1(19)-specific invasion-inhibitory antibodies. The results revealed that the acquisition of MSP1(19)-specific invasion-inhibitory antibodies required 2 or more P. falciparum infections. In contrast, enzyme-linked immunosorbent assays on the same serum samples showed that MSP1(19)-specific antibodies are present after the first malaria infection. This delay in the acquisition of functional antibodies by residents of areas where malaria is endemic is consistent with the observation that multiple malaria infections are required before clinical immunity is acquired.

References

Jul 31, 1998·Annals of Tropical Medicine and Parasitology·J K Baird
Aug 31, 2002·The American Journal of Tropical Medicine and Hygiene·Erika Martins BragaAntoniana Ursine Krettli
Oct 5, 2002·The American Journal of Tropical Medicine and Hygiene·Damon P EisenRoss L Coppel
Sep 27, 2003·Annals of Tropical Medicine and Parasitology· KrisinJ K Baird
Sep 27, 2003·Annals of Tropical Medicine and Parasitology·J K BairdW Kalalo
Sep 13, 2006·Parasite Immunology·F C Hartgers, M Yazdanbakhsh
Nov 4, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Arlene DentChristopher L King

❮ Previous
Next ❯

Citations

May 7, 2009·Immunology and Cell Biology·Jack S Richards, James G Beeson
Apr 18, 2012·Human Vaccines & Immunotherapeutics·Christopher J A DuncanRuth D Ellis
Jul 9, 2010·Journal of Leukocyte Biology·Matthew B B McCall, Robert W Sauerwein

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Antibody Specificity

Antibodies produced by B cells are highly specific for antigen as a result of random gene recombination and somatic hypermutation and affinity maturation. As the main effector of the humoral immune system, antibodies can neutralize foreign cells. Find the latest research on antibody specificity here.

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.